This laboratory recently identified a human gene that encodes a novel folate transporter [Homo sapiens proton-coupled folate transporter (HsPCFT); SLC46A1] required for intestinal folate absorption. This study focused on mouse (Mus musculus) PCFT (MmPCFT) and rat (Rattus norvegicus) PCFT (RnPCFT) and addresses their secondary structure, specificity, tissue expression, and regulation by dietary folates. Both rodent PCFT proteins traffic to the cell membrane with the NH 2-and COOHtermini accessible to antibodies targeted to these domains only in permeabilized HeLa cells. This, together with computer-based topological analyses, is consistent with a model in which rodent PCFT proteins likely contain 12 transmembrane domains. Transport of [ 3 H]folates was optimal at pH 5.5 and decreased with increasing pH due to an increase in K m and a decrease in Vmax. At pH 7.0, folic acid and methotrexate influx was negligible, but there was residual (6S)5-methyltetrahydrofolate transport. Uptake of folates in PCFT-injected Xenopus oocytes was electrogenic and pH dependent. Folic acid influx K m values of MmPCFT and RnPCFT, assessed electrophysiologically, were 0.7 and 0.3 M at pH 5.5 and 1.1 and 0.8 M at pH 6.5, respectively. Rodent PCFTs were highly specific for monoglutamyl but not polyglutamyl methotrexate. MmPCFT mRNA was highly expressed in the duodenum, proximal jejunum, liver, and kidney with lesser expression in the brain and other tissues. MmPCFT protein was localized to the apical brush-border membrane of the duodenum and proximal jejunum. MmPCFT mRNA levels increased ϳ13-fold in the proximal small intestine in mice fed a folate-deficient vesus folatereplete diet, consistent with the critical role that PCFT plays in intestinal folate absorption.
FOLATES are essential one-carbon donors critical for nucleic acid synthesis and methylation reactions (28) . The requirement for this B vitamin is met entirely from the absorption of dietary folates in the proximal small intestine. Recently, this laboratory identified a novel folate transporter [Homo sapiens protoncoupled folate transporter (HsPCFT); SLC46A1, GenBank Accession No. NP_542400], which is highly expressed in the human proximal small intestine with functional characteristics similar to what is observed in intestinal folate absorption and transport into cells and membrane vesicles of intestinal origin (22) . This transporter was shown to be mutated with a loss of function in the autosomal recessive disorder hereditary folate malabsorption (22, 37) . These observations established HsPCFT as essential for intestinal folate absorption and homeostasis in humans (22) . Low-pH folate transport activities, with properties similar to those of PCFT, have also been observed in a variety of other normal tissues (liver, kidney, and retina) along with murine and human cancer cell lines (1, 8, 9, 26, 27, 35) .
Prior to the identification of HsPCFT, the reduced folate carrier (RFC), an anion exchanger, was often considered to represent the mechanism of intestinal folate absorption because it is highly expressed along the entire intestinal apical brushborder membrane and its expression is increased under conditions of folate deficiency (4, 15, 23) . However, RFC-mediated transport has a pH optimum of 7.4 and a specificity profile (very low affinity for folic acid; influx K i : ϳ200 M) that is very different from that observed for folate transport in the intestine and in cells and membrane vesicles of intestinal origin (low pH optimum, high affinity for folic acid; influx K m : ϳ0.5 M) (16, 30) . Further evidence that the intestinal folate absorptive process is genetically distinct from RFC came from studies in which the low-pH folate transport activity was preserved in cell lines of intestinal and other tissue origins even when RFC was deleted from the genome or mutated with a loss of function (3, 29, 35, 36) .
The present study addresses the functional properties and secondary structure of PCFT orthologs in the mouse [Mus musculus (Mm)PCFT] and rat [Rattus norvegicus (Rn)PCFT] along with the tissue expression pattern, specificity, and regulation in mice in response to dietary folate restriction. These experiments provide fundamental information necessary for the further characterization of the role of PCFT in mouse development and folate delivery to intestinal and other tissues and for the investigation of PCFT as a factor in the pathogenesis of cancer in mouse models. were obtained from Moravek Biochemicals (Brea, CA) and purified as previously described (5) . MTX di-, tri-, tetra-, penta-, and hexaglutamates, (6S)5-methylTHF, and (6S)-and (6R)5-formyltetrahydrofolate (5-formylTHF) were ob-tained from Schircks Laboratories (Jona, Switzerland). PT523, a MTX analog, was obtained from Andre Rosowsky (Dana Farber Cancer Institute, Boston, MA). Folic acid, MTX, and other chemicals were obtained from commercial sources.
MATERIALS AND METHODS

Reagents
Plasmid construction. Full-length MmPCFT and RnPCFT cDNA clones were obtained from Open Biosystems (Huntsville, AL). The open reading frames (ORFs) were PCR amplified with PfuUltra DNA polymerase (primers are shown in Table 1 ) and subsequently cloned into the BglII site of the pS64T vector for in vitro transcription of the capped sense MmPCFT and RnPCFT cRNA from a SP6 promoter using the mMESSAGE mMACHINE system (Ambion, Austin, TX) and into the BamHI site of pcDNA3.1(ϩ) to generate pcDNA3.1(ϩ)MmPCFT and pcDNA3.1(ϩ)RnPCFT, respectively. MmPCFT and RnPCFT ORFs were tagged at either NH 2-or COOHtermini with a hemaglutinin (HA) epitope by PCR (primers shown in Table 1 ) and cloned into pcDNA3.1(ϩ) with the same strategy as above. cDNA inserts were verified by DNA sequencing at the Albert Einstein Cancer Center Genomics Shared Resource.
Cell culture and transfection. HeLa and HepG2 cells obtained from the American Type Culture Collection (Manassas, VA) were maintained as previously described (30) . Plasmid DNA was transfected into these cells using Lipofectamine 2000 (Invitrogen). HepG2 cells stably transfected with either pcDNA3.1(ϩ), pcDNA3.1(ϩ)MmPCFT, or pcDNA3.1(ϩ)RnPCFT were generated by G418 selection (600 g/ml).
Experiments in mice. The impact of dietary folate restriction on PCFT mRNA levels was assessed in 3-to 4-mo-old male C57BL/6 specific pathogen-free mice. Animals were maintained on either folate-containing mouse chow (2 mg/kg folic acid) or a folic acid-free diet over 8 wk, after which they were killed in a CO 2 chamber. The proximal small intestine was dissected and rinsed in ice-cold PBS (pH 7.4), and total RNA was isolated with TRIzol reagent (Invitrogen). Data on RFC and folate receptor (FR)-␣ levels in these animals have been previously reported (15) .
For immunohistochemical experiments, C57BL/6 adult mice maintained on the usual mouse chow were killed, and segments of intestines were dissected, rinsed in ice-cold PBS (pH 7.4), and embedded in freezing embedding OCT medium (Andwin Scientific, Addison, IL) for cryosectioning at 5 m thickness. Similar intestine segments were dissected for the isolation of total RNA.
Production of peptide antibody and immunohistochemistry. Antiserum specific for MmPCFT protein was custom made by Open Biosystems in rabbits using the peptide corresponding to amino acids 446 -459 ([C]EKVNPHPEFQQFPQSP) of MmPCFT protein as the antigen. Antibodies specific for MmPCFT were affinity purified with the Sulfolink Trial Kit (Pierce). Rabbit anti-HA antibody was obtained from Sigma-Aldrich. Immunofluorescence was performed using either affinity-purified anti-MmPCFT or anti-HA antibodies and secondary swine anti-rabbit IgG antibody conjugated with FITC (DAKO, Carpinteria, CA). HeLa cells were stained with or without permeabilization in 0.2% Triton X-100 in PBS (pH 7.4) for 15 min, and fluorescence was visualized on an Olympus IX70 Inverted Epifluorescence Microscope (Center Valley, PA).
Preparation of cryosections of mouse tissues and immunochemistry with affinity-purified anti-MmPCFT antibody followed procedures previously described (31) . The specificity of the anti-MmPCFT antibody was confirmed by blocking the immunohistochemical staining ofMmPCFT with the peptide antigen (200 g/ml).
SDS-PAGE and Western blot analysis. HepG2 or HeLa cell membrane fractions were prepared using previously reported procedures (22 (22, 24) . Initial uptake kinetics for tritiated folates were measured over a 2-min interval. This resulted in a small (ϳ30%) decrease in extracellular folate, due to cellular uptake, at the lowest concentration studied (0.1 M). This decreased as the extracellular folate level increased and became negligible at concentrations Ͼ1.0 M. This resulted in a small overestimation of K m; this would not be a factor in influx kinetic measurements obtained electrophysiologically.
To assess the effects of antiserum on folic acid uptake mediated by MmPCFT, stably transfected HepG2 cells were washed twice in HBS [20 mM HEPES, 140 mM NaCl, 5 mM KCl, 2 mM MgCl 2, and 5 mM dextrose (pH 7.4)] and then incubated with 1 ml of HBS (pH 7.4) containing preimmune or anti-MmPCFT serum (1:50 dilution) at 37°C and pH 7.4 for 20 min. MgCl2, and 5 mM dextrose) at pH 5.5 or 6.5 containing either preimmune or anti-MmPCFT serum (1:50 dilution) at 37°C for 2 min.
To examine the effects of sodium on the transport activities of MmPCFT or RnPCFT, [ 3 H]folic acid (0.5 M) uptake was assessed in MBS (pH5.5) over 2 min in which 140 mM NaCl was replaced by the same concentration of choline chloride. Uptake was normalized to protein content.
Electrophysiological analyses in Xenopus oocytes. Preparation and microinjection with 50 nl of water or PCFT cRNA (30 -50 ng) into defolliculated Xenopus laevis oocytes followed previously described procedures; oocytes were kept at 17°C in horse serum medium [82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl 2, 2.3 mM CaCl2, 5 mM HEPES, and 5% horse serum (pH 7.5)], and electrophysiological recordings in a solution of 90 mM NaCl, 1 mM KCl, 1 mM MgCl 2, 1.8 mM CaCl2, 5 mM Tris, and 5 mM MES were conducted 3-7 days after cRNA injection (10, 22) . For the determination of K m values, currents were measured at different folate concentrations with the membrane potential clamped at Ϫ80 mV. Influx kinetic constants were obtained from the normalized currents from different experiments fitted to the following equation: I ϭ (I max ϫ S)/(Km ϩ S), where I is the current induced by a given substrate concentration (S) and Imax is the maximal current generated.
Northern blot analysis. A Northern blot containing polyA ϩ RNA (2 g/lane) from 12 mouse tissues was obtained from Origene (Rockville, MD). [
32 P]dCTP-labeled cDNA probes were made from a MmPCFT cDNA segment (1094 -1440 bp, GenBank Accession No. NM_026740) and hybridized to the membrane as previously described (22) . After the membrane had been stripped, ␤-actin mRNA was probed as the loading control.
Total RNA (10 g) isolated from different intestinal segments was resolved on a 1% denaturing agarose gel and transferred to a Nytran nylon membrane (Whatman, Florham Park, NJ). Northern blot hybridization was subsequently performed using the [ 32 P]dCTP-labeled MmPCFT cDNA probe described above. 18S and 28S rRNAs were visualized after ethidium bromide staining as the loading control.
Quantitative RT-PCR. Total RNA isolated from mice fed folatereplete or folate-deficient diets, as previously reported (15) and described above, was reverse transcribed to cDNA with Superscript Reverse Transcriptase II (Invitrogen). Real-time PCR was performed with SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and primers specific for MmPCFT (Table 1) . GAPDH was simultaneously amplified with specific primers (Table 1) to normalize MmPCFT expression.
RESULTS
Structural analysis of MmPCFT and RnPCFT. MmPCFT
and RnPCFT (GenBank Accession Nos. AAH57976 and AAH89868, respectively) were identified in the National Center for Biotechnology Information (NCBI) GenBank database based on high amino acid identity to human PCFT protein. The human, mouse, and rat orthologs encode proteins of 459 amino acids with a predicted molecular weight of ϳ50 kDa (Fig. 1A) . PCFT proteins are highly conserved in mammals. Based on sequence alignment analysis with ClustalW (13), the predicted MmPCFT and RnPCFT proteins share 95% amino acid identity to each other, 87% identity to HsPCFT, and Ͼ80% identity to their counterparts in other mammalian species, e.g., the dog (Canis familiaris; XP_548286), rhesus monkey (Macaca mulatta; XP_001106954), and domestic cow (Bos taurus; XM_588367) ( Fig. 1, A and B) . PCFT orthologs also appear to be present in nonmammalian vertebrates, e.g., the chicken [Gallus gallus (GgPCFT); XP415815], African clawed frog [X. laevis (XlPCFT); AAH77859], and zebrafish [Danio rerio (DrPCFT); AAH49421], all of which share Ͼ50% amino acid identity to mammalian PCFTs (Fig. 1B) . No invertebrate homologs could be identified in the NCBI GenBank database with Ͼ30% amino acid identity to vertebrate PCFTs.
MmPCFT and RnPCFT genes are located at Chr11B5 and Chr10q25, respectively, and have the same gene structure as HsPCFT (Chr17q11.2): five exons and four introns with exons highly conserved between these three species (Fig. 1C) . Similar gene structure and exon conservation are also present in other PCFT genes, for instance, the dog (GeneID: 491166), rhesus monkey (GeneID: 708727), domestic cow (GeneID: 511097), and chicken (GeneID: 417569). The zebrafish (GeneID: 393255) gene contains six exons and five introns; exons 2 and 3 of the DrPCFT gene correspond to exon 2 of the mammalian and chicken PCFT genes. Fig. 1A and indicates the high degree of homology within TMDs among human and rodent transporters.
An immunohistochemistry approach was used to assess the location of the NH 2 -and COOH-termini of rodent PCFT proteins. MmPCFT and RnPCFT were tagged with an HA epitope at either terminus, and the fusion proteins were subsequently immunodetected with an anti-HA antibody in HeLa cells transiently transfected with each construct with or without permeabilization before being immunostained. As shown in Fig. 2A , MmPCFT and RnPCFT HA fusion proteins could only be localized to the plasma membrane of permeabilized cells (top); these epitopes could not be stained in cells that were not permeabilized (bottom). Similar immunolocalization was also observed for wild-type MmPCFT expressed in HeLa cells ( Fig.  2A , wild-type MmPCT), which could only be stained in permeabilized cells with an anti-MmPCFT peptide antibody that specifically recognizes an epitope in the COOH-terminus. These observations are consistent with an intracellular localization of the NH 2 -and COOH-termini of MmPCFT and RnPCFT and a predicted topology in which there are an even number of transmembrane segments, likely 12 transmembrane segments, as based on the topological analyses.
When cDNAs encoding wild-type or HA-tagged transporters were transiently transfected into HeLa cells, all the constructs noted above produced [ 3 H]MTX influx activity comparable with that of cells transfected with native MmPCFT and RnPCFT, which was Ͼ14 times higher than cells transfected with vector control alone (Fig. 2B, mock) and consistent with their plasma membrane localization and the reported folate transport activity for the human gene (22) . This also indicates that the HA epitope at either the NH 2 -or COOH-terminus does not alter the transport activity of MmPCFT or RnPCFT.
Anti-MmPCFT serum, which specifically recognizes the COOH-terminus of the murine transporter, did not alter folic acid uptake in HepG2 cells stably transfected with MmPCFT, further supporting the intracellular localization of the COOHterminus of MmPCFT protein (Fig. 2C) .
Using anti-MmPCFT serum, MmPCFT protein was detected as broad bands in the Western blot analysis in both transiently transfected HeLa cells and stably transfected HepG2 cells with molecular weights higher than predicted (ϳ50 kDa) (Fig. 2D) . This is consistent with the N-linked glycosylation site(s) in the extracellular loop between TMD 1 and TMD 2, which are highly conserved among rodent and human PCFTs (Fig. 1A) and have been confirmed in other studies by this laboratory (unpublished observations). In both HepG2 and HeLa transfectants, there was a band at ϳ35 kDa detected in both mockand MmPCFT-transfected HeLa and HepG2 cells that disappeared in the presence of blocking peptide. 3C) by MmPCFT and RnPCFT in stably transfected HepG2 cells was highly pH dependent, decreasing as pH was increased from pH 5.5 to 7.4. Whereas there was negligible folic acid and MTX transport at pH 7.0, there was residual activity for (6S)5-methylTHF at this pH. There was ϳ50% of maximum activity for all these folate substrates at pH 6.0, the pH at the upper small intestinal absorptive surface (17) . [ 3 H]folic acid transport mediated by MmPCFT and RnPCFT in stably transfected HepG2 cells was not sodium dependent; influx of both species was the same in sodium-containing buffer and buffer in which sodium was replaced by choline (Fig. 3D) .
Electrophysiological characterization of MmPCFT and RnPCFT in Xenopus oocytes. Xenopus oocytes injected with either
MmPCFT or RnPCFT cRNA displayed currents induced by folic acid, (6S)5-methylTHF, or MTX in two-electrode voltage-clamp experiments (shown for folic acid in Fig. 3E) ; no currents were induced by folates in water-injected oocytes. In general, the folate-induced current amplitude was greater with MmPCFT than with RnPCFT. Folic acid-induced current amplitudes were proportional to the applied transmembrane voltage in oocytes expressing either MmPCFT (Fig. 3F) fected with cDNAs encoding MmPCFT and RnPCFT followed Michaelis-Menten kinetics (as illustrated for folic acid in Fig. 4A ). Folic acid-induced currents in Xenopus oocytes injected with MmPCFT cRNA was saturable with increasing substrate concentrations at both pH 5.5 and 6.5 (Fig. 4B) . Table 2 shows data comparing relative influx K m values for the various folates for mouse and rat PCFTs at pH 5.5 versus 6.5. Both MmPCFT and RnPCFT had comparable high affinities for folic acid at pH 5.5. When pH was increased from 5.5 to 6.5, the K m value for folic acid, (6S)5-methylTHF, and MTX was in- , respectively. There was a lesser change in influx K m values for folic acid over this pH range, with no change for (6S)5-methylTHF as assessed by electrophysiological measurements in Xenopus oocytes (Table 2) . K m values were somewhat overestimated using tritiated folates due to substrate depletion at low concentrations, which could account for differences in this parameter based on current measurements (see MATERIALS AND METHODS). In addition, these differences might be due to voltage-related changes in K m that occur during electrophysiological measurements.
MmPCFT and RnPCFT substrate specificity. Influx of 0.5 M [
3 H]folic acid was assessed at pH 5.5 in the absence (control) or presence of a 10-fold (5 M) higher concentration of nonlabeled folates or antifolates in MmPCFT-, RnPCFT-, and mock-transfected HepG2 cells. As shown in Fig. 4C , there was substantial inhibition of [ 3 H]folic acid uptake by folates and antifolates. The most potent inhibitors were pemetrexed and (6S)5-formylTHF followed by folic acid and (6S)5-methylTHF and then MTX and ZD1694 (P Ͻ 0.001). The unnatural (6R) isomer of 5-formylTHF was a weaker inhibitor than the natural (6S) isomer (P Ͻ 0.001, as assessed by one-way ANOVA followed by Tukey's test). PT523, a 4-amino folic acid (aminopterin) analog with a hemiphthaloyl-L-ornithine side chain, did not inhibit at all.
As shown in Fig. 4D , whereas uptake of 0.5 M [ 3 H]MTX at pH 5.5 mediated by MmPCFT and RnPCFT was nearly abolished by 50 M nonlabeled MTX monoglutamate, the same concentration of MTX di-, tri-, tetra-, penta-, or hexaglutamate had no inhibitory effect at all, indicating that MmPCFT and RnPCFT are highly specific for monoglutamyl forms of folates.
Expression of PCFT mRNA and protein in mouse tissues. MmPCFT mRNA, with a molecular size of ϳ2.2 kb, was abundantly expressed in the small intestine, liver, and kidney and to a lesser extent in the brain, testis, skin, and stomach (Fig. 5A ). There were low levels in the heart and lung, very low levels in the spleen and thymus, and no detectable MmPCFT mRNA in skeletal muscle. A shorter isoform of MmPCFT mRNA, with a molecular size of ϳ1.3 kb, was also detected in the brain, kidney, liver, skin, small intestine, and stomach. Focusing on the intestinal tract, MmPCFT mRNA was highly expressed in the duodenum and proximal jejunum, with lower expression in the distal jejunum and even lower levels in the cecum and colon (Fig. 5B) . There was just a trace of expression in the ileum and rectum.
MmPCFT protein localization was analyzed by immunohistochemistry using affinity-purified polyclonal anti-MmPCFT antibody. As shown in Fig. 5C , there was substantial expression of MmPCFT protein in the duodenum and proximal jejunum localized exclusively to the apical brush-border membrane. The peptide antigen used to produce the anti-MmPCFT antibody completely blocked staining of MmPCFT, consistent with the high specificity of this antibody for MmPCFT protein.
Alterations in MmPCFT mRNA levels in the proximal small intestine in response to dietary folate. A previous study (15) demonstrated that folate deprivation in mice resulted in increased levels of both FR-␣ and RFC mRNA. Using the RNA from these animals, we assessed the impact of folate deprivation on PCFT mRNA in the proximal small intestine in mice on a normal chow diet versus mice on a folate-deficient diet. As shown in Fig. 6 , inset, MmPCFT mRNA levels were increased in each of 10 folate-deficient mice compared with folatereplete mice (n ϭ 7) without an overlap in levels between the two groups. Overall, the MmPCFT mRNA level was increased by a factor of ϳ13 in folate-deficient mice compared with folate-replete mice (Fig. 6) .
DISCUSSION
The present study demonstrates that murine and rat PCFTs, like the human ortholog, are high-affinity carriers with a high degree of specificity for folates. Both MmPCFT and RnPCFT are highly specific for monoglutamate MTX but not polyglutamate derivatives of MTX. This explains, at the molecular level, why the transport of dietary folates across the luminal brush-border membranes of proximal small intestinal epithelial cells requires the hydrolysis of folate polyglutamates by ␥-glutamyl carboxypeptidase II to monoglutamate forms before transport into enterocytes can occur (7) .
Transport of folic acid, (6S)5-methylTHF, and MTX by mouse and rat PCFTs expressed in Xenopus oocytes was electrogenic, consistent with a net charge translocation during folate transport. The magnitude of the current was dependent on the extracellular folate concentration and on the extracellular pH. Alterations in protonation of the folate molecule do not occur over the pH range of 5.5 to 7.4 (20) ; however, at lower pHs, these measurements would be complicated by changes in substrate protonation, which, in turn, changes the concentration of the substrate recognized by the transporter. The change in current amplitude as a function of pH, under conditions in which changes in protonation of the folate molecule do not occur, suggest that pH changes not only alter the magnitude of the driving force for folate transport but may also titrate amino acids within PCFT that result in an alteration in the rate of transport. Studies are underway to identify the amino acids involved in these pH-dependent effects.
MmPCFT has been previously reported to be a heme carrier protein (HCP1) that transports heme with low affinity (ϳ125 M) and independent of pH (14, 25) . Within the context of that report, HCP1 was predicted to consist of nine transmembrane domains with the NH 2 -and COOH-termini located intracellularly and extracellularly, respectively. However, the present study, along with the previous report from this laboratory, indicates that transport mediated by this carrier is highly specific and pH dependent for folates, with an affinity at least two orders of magnitude higher than that reported for hemin. These data, together with topological prediction based on multiple hydropathy analyses, also support intracellular localization of both the NH 2 -and COOH-termini of MmPCFT and RnPCFT expressed in HeLa cells and an even number of transmembrane segments, most likely 12. However, in view of the limitations of the methodologies employed, confirmation of the localization of the NH 2 -and COOH-termini and other elements of this transporter will require further verification of the secondary structure.
The functional properties of MmPCFT and RnPCFT are consistent with the folate transport activities that have been Fig. 6 . MmPCFT mRNA levels in the mouse proximal small intestine as a function of the dietary folate level. Mice were fed either a folate-replete or folate-deficient diet, after which PCFT levels in the proximal intestine were quantified by real-time RT-PCR. Data were normalized to GAPDH mRNA levels and presented as average fold changes relative to the average MmPCFT level in mice fed a folate-replete diet (assigned a value of 1). Inset: MmPCFT mRNA levels in individual mice from these two groups. Each symbol indicates an individual mouse. Data are means Ϯ SE from 3 separate measurements.
reported for rat and mouse intestinal segments, brush-border membranes, and intestinal cell lines that have a low pH maximum (16, 29) . Both transporters have a high level of folate transport activity at pH 6.0, the pH at the apical surface of the proximal small intestinal epithelium (17) . MmPCFT mRNA and protein were highly expressed in the duodenum and upper jejunum with the protein exclusively localized to the brush-border membrane, consistent with its functional role as the rate-limiting first step in the absorption of dietary folates. The functional role of MmPCFT in intestinal folate absorption is further supported by the observation that MmPCFT mRNA levels in the murine proximal small intestine increased 13-fold in mice fed a folate-deficient diet. It is of interest that both RFC and FR-␣ mRNA levels also increased in the same tissues from the same mice on a folate-deficient diet, indicating that expression of all these transporters is folate responsive (15) . However, it is only PCFT that, in fact, mediates the translocation of folates at the acidic environment of the proximal small intestine at usual dietary folate levels. This conclusion is based on the observation that this gene is mutated in patients with hereditary folate malabsorption. Hence, this folate-responsive regulation of the PCFT gene is particularly important in folate deficiency states. It is possible, however, that some RFCmediated transport can occur with the administration of pharmacological doses of folates, as in the treatment of hereditary folate malabsorption (6) .
In addition to its high expression in the small intestine at the sites of folate absorption, PCFT is also highly expressed in other tissues. Very high expression of MmPCFT mRNA was observed in the liver and kidney, tissues that manifest a high level of folate transport activity at low pH (1, 9). The major fraction of folates in the glomerular filtrate, which is at pH 6.8 (11) , are reabsorbed at the proximal tubules. At this pH, PCFT has substantial folate transport activity, suggesting that it may play a direct role in reabsorption of folates at this site. This is supported by the presence of substantial low pH folate transport activity in brush-border membrane vesicles from the rat kidney (1) . The contribution of PCFT to folate transport in the liver, where it is also highly expressed, is not clear. Transport of folates into the liver from the arterial system occurs at neutral pH; however, the pH within the hepatic portal sinusoids, where folates are delivered via the portal system from the intestine to hepatocytes, is not known and may be acidic (9) . Data for human and rodent PCFTs indicate that there is residual 5-methylTHF transport activity at pH 7.0 so that this carrier can operate, albeit less efficiently, at neutral pH.
Beyond transport at the level of the cell membrane, PCFT may have other functions. For instance, this carrier may be incorporated into membrane vesicles that accommodate folate receptors and transport folates by receptor-mediated endocytosis or transcytosis (33) . FR-␣ is highly expressed at the apical proximal renal tubule membrane and has been suggested to be a major route of folate reabsorption in the kidney (2) . Folates bind to FRs that are anchored to the cell membrane via a glycosylphosphoinositol moiety. The resultant complex is internalized in a vesicle that traffics, intact, within the cytoplasm, where it is acidified, resulting in the release of the folate molecule from receptor (18, 19, 34) . The mechanism by which folate is then exported from the vesicle has not been clarified. If PCFT is present in these endocytic vesicles, it could provide the route of folate transport into the cytoplasm using the outward transvesicular proton gradient. Such a mechanism has been proposed earlier, although the identity of a vesicular transporter that could function at low pH is not known (12, 21) . This mechanism could also explain, in part, why patients with hereditary folate malabsorption have a defect in folate transport into the central nervous system where the pH is neutral at the transport site but FR-␣ is highly expressed at the choroid plexus (32) . The detection of substantial levels of PCFT mRNA in the mouse brain is consistent with this hypothesis.
Analysis of the NCBI GenBank genome database shows that PCFT is highly conserved in other mammalian species at the level of both the gene and primary protein structures, e.g., in the dog, rhesus monkey, and domestic cow and, to a lesser extent, in nonmammalian vertebrates such as birds, amphibians, and fish. Together with its functional conservation in humans, mice, and rats, this suggests that PCFT is evolutionarily conserved for intestinal folate absorption in mammalian species and likely plays this role in nonmammalian vertebrates as well. PCFT does not appear to be conserved in invertebrates according to a protein-protein BLAST search of the NCBI GenBank database using vertebrate PCFTs as queries, suggesting that this gene might have originated and evolved in vertebrates.
